Nutra Pharma Corp.
OTC: NPHC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Michael D. Flax
- Employees
- 4
- Headquarters
- Plantation, United States
- IPO year
- 2001
- Market cap
- $1.4M
- Website
- https://www.nutrapharma.com
Loading NPHC…
Loading profile data…Frequently asked questions about NPHC
What does Nutra Pharma Corp. (NPHC) do?
Nutra Pharma Corp. (NPHC) operates as a biopharmaceutical firm specializing in obtaining, licensing, and bringing to market a variety of pharmaceutical products, cutting-edge technologies, and both homeopathic and ethical medications. The company primarily targets the U.S. market, focusing its efforts on managing conditions such as pain, neurolo...
Where does NPHC trade?
Nutra Pharma Corp. (NPHC) trades on the Other OTC.
What sector is NPHC in?
Nutra Pharma Corp. (NPHC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nutra Pharma Corp.?
Michael D. Flax is the chief executive officer of Nutra Pharma Corp. (NPHC).
Where is Nutra Pharma Corp. headquartered?
Nutra Pharma Corp. is headquartered in United States.
Does NPHC pay a dividend?
Nutra Pharma Corp. (NPHC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NPHC go public?
Nutra Pharma Corp. (NPHC) completed its initial public offering in 2001.